Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Tretinoin may help kidney cancer cells develop into normal cells. Interferon alfa
may interfere with the growth of cancer cells.
PURPOSE: Phase II trial to study the effectiveness of liposomal tretinoin plus interferon
alfa in treating patients who have metastatic kidney cancer.